Which declaration accepted therapeutic abortion?
True about measles vaccine is that it is:
What is the next step in the management of a patient with a positive sputum smear for tuberculosis but a negative chest X-ray?
The 'Rule of Halves' is primarily related to which of the following?
What is the Bacterial Index used to assess?
What is the Body Mass Index (BMI) criterion for morbid obesity?
In the Rabies vaccine schedule of 0, 3, 7, 14, 30, 90 days, what does the '0' represent?
Arrange the following causes of NCD deaths as per decreasing order of frequency: Cancers, Cardiovascular diseases, Diabetes, Respiratory diseases?
Which WHO STEPS program is used for non-communicable diseases?
In calculating the literacy rate, which parameter is taken into account?
Explanation: ### Explanation **Correct Answer: B. Declaration of Oslo (1970)** The **Declaration of Oslo**, adopted by the World Medical Association (WMA) in 1970, specifically addresses **Therapeutic Abortion**. It establishes the ethical framework that while a physician’s primary duty is to preserve life, they may perform an abortion as a therapeutic measure if the pregnancy poses a serious threat to the health or life of the mother. It also protects the "Conscientious Objection" clause, allowing doctors to refuse to perform the procedure if it conflicts with their moral beliefs, provided they ensure the patient receives care elsewhere. **Analysis of Incorrect Options:** * **A. Declaration of Geneva (1948):** Known as the modern-day "Physician’s Oath." It was adopted post-WWII to reaffirm humanitarian duties but does not specifically address abortion. * **C. Declaration of Helsinki (1964):** This is the gold standard for **Ethical Principles for Medical Research involving human subjects**. It focuses on informed consent and the safety of trial participants. * **D. Declaration of Tokyo (1975):** This declaration outlines the guidelines for physicians concerning **Torture** and other cruel, inhuman, or degrading treatment or punishment in relation to detention and imprisonment. **High-Yield Clinical Pearls for NEET-PG:** * **MTP Act (India), 1971:** Inspired by the global shift seen in the Oslo Declaration. Note the 2021 amendment: Upper limit for abortion is now **24 weeks** for special categories of women. * **Declaration of Sydney:** Relates to the **Definition of Death**. * **Declaration of Venice:** Relates to **Terminal Illness** and end-of-life care. * **Declaration of Taipei:** Relates to **Health Databases** and Biobanks.
Explanation: **Explanation:** **1. Why Option A is Correct:** The measles vaccine is a **live-attenuated vaccine** (Edmonston-Zagreb strain) that is highly sensitive to heat, making it **thermolabile**. It is one of the most heat-sensitive vaccines in the Universal Immunization Programme (UIP). Exposure to temperatures above the recommended range (2°C to 8°C) or sunlight leads to a rapid loss of potency. Because of its thermolability, it must be stored in the coldest part of the ice-lined refrigerator (ILR) and transported in a cold chain. **2. Why Other Options are Incorrect:** * **Option B (Thermostable):** Thermostable vaccines (like Tetanus Toxoid) can withstand higher temperatures for longer periods without losing efficacy. Measles does not fall into this category. * **Option C (Botulism antitoxin):** This is a passive immunizing agent used to treat botulism poisoning. It is unrelated to the measles vaccine, which provides active immunity. **3. High-Yield Clinical Pearls for NEET-PG:** * **Reconstitution:** Once reconstituted with the provided diluent (Sterile Water), the measles vaccine becomes even more unstable. It **must** be used within **4 hours**; any leftover vaccine must be discarded to prevent Toxic Shock Syndrome (usually caused by *Staphylococcus aureus* contamination). * **Storage:** At the district level, it is stored at -20°C. At PHCs/CHCs, it is stored at +2°C to +8°C. * **VVM (Vaccine Vial Monitor):** The measles vaccine vial features a VVM on the **cap** (not the label), which is a crucial indicator of heat exposure. * **Administration:** Given at 9 completed months (1st dose) and 16-24 months (2nd dose) via the **Subcutaneous (SC)** route in the right upper arm.
Explanation: **Explanation:** The diagnosis of Pulmonary Tuberculosis (PTB) in the National Tuberculosis Elimination Programme (NTEP) is primarily microbiological. A positive sputum smear indicates the presence of acid-fast bacilli (AFB), which is sufficient evidence of active disease, regardless of radiological findings. **1. Why Option B is Correct:** In clinical practice, a positive sputum smear has high specificity. A negative chest X-ray (CXR) does not rule out TB, as early-stage disease or endobronchial TB may not show visible parenchymal shadows. According to NTEP guidelines, any "Microbiologically Confirmed" case must be initiated on **Anti-Tuberculosis Treatment (ATT)** immediately to interrupt the chain of transmission and prevent clinical deterioration. **2. Why Other Options are Incorrect:** * **Option A & D:** Repeating tests (CXR or Smear) leads to unnecessary "diagnostic delay." A single positive smear is diagnostic in a symptomatic patient. * **Option C:** While CBNAAT (GeneXpert) is the preferred initial diagnostic tool under NTEP for its high sensitivity and ability to detect Rifampicin resistance, the question states the patient is *already* smear-positive. Treatment should not be withheld while waiting for further tests unless drug resistance is specifically suspected. **Clinical Pearls for NEET-PG:** * **Microbiologically Confirmed TB:** Defined as a patient with a biological specimen positive for AFB by smear microscopy, or positive for *M. tuberculosis* by NAAT (like CBNAAT/Truenat) or culture. * **Radiology vs. Microbiology:** Microbiology is the "Gold Standard." A positive smear always supersedes a negative X-ray. * **Infectivity:** Smear-positive patients are the most infectious; prompt ATT is the most effective public health intervention to reduce the "Annual Risk of Tuberculosis Infection" (ARTI).
Explanation: **Explanation:** The **'Rule of Halves'** is a classic epidemiological concept used to describe the status of **Hypertension** management in a community. It highlights the significant gap between the prevalence of the disease and its effective control. **The Rule states that:** * **Half** of the people with high blood pressure are **not known** (undiagnosed). * **Half** of those known to have hypertension are **not on treatment**. * **Half** of those receiving treatment do **not have their blood pressure controlled** to target levels. This concept emphasizes that only about **1/8th (12.5%)** of the hypertensive population in a community actually achieves adequate therapeutic control. **Analysis of Incorrect Options:** * **Obesity:** While obesity is a major risk factor for hypertension, it does not follow the "Rule of Halves." Assessment usually involves BMI or waist-hip ratios. * **Burns:** The "Rule of Nines" (Wallace Rule) is used in burns to estimate the Total Body Surface Area (TBSA) involved, not the Rule of Halves. * **Blindness:** Blindness statistics are tracked via prevalence rates and the "WHO Vision 2020" targets, but no "Rule of Halves" is applied to its epidemiology. **High-Yield Pearls for NEET-PG:** * **Iceberg Phenomenon:** Hypertension is a classic example of the "Iceberg of Disease," where the diagnosed cases represent only the tip, and the undiagnosed cases represent the submerged portion. * **Screening:** Hypertension screening is a form of **Secondary Prevention**. * **Tracking:** The phenomenon where a child’s BP stays in the same percentile as they grow is called "Tracking of Blood Pressure." * **Rule of Halves** is also occasionally discussed in the context of other chronic "silent" diseases like Diabetes, but it is classically and primarily associated with **Hypertension** in standard textbooks (Park’s PSM).
Explanation: **Explanation:** **Bacterial Index (BI)** is a semi-quantitative measure used to assess the density of *Mycobacterium leprae* in a patient. It is calculated based on the number of acid-fast bacilli (AFB) seen in skin smears (earlobes, forehead, chin, and extensor surfaces) under an oil immersion lens. The scale ranges from **0 to 6+** (Ridley’s Logarithmic Scale). 1. **Why Leprosy is Correct:** In Leprosy, the BI is crucial for classification and monitoring treatment. A BI of **≥1** at any site classifies the case as **Multibacillary (MB)** leprosy, while a BI of **0** at all sites indicates **Paucibacillary (PB)** leprosy. It reflects the total bacterial load (live and dead bacilli) in the body. 2. **Why Incorrect Options are Wrong:** * **Tuberculosis:** While also caused by acid-fast bacilli (*M. tuberculosis*), the severity is typically assessed via sputum grading (1+, 2+, 3+) or the **Morphological Index** (not BI) if looking at viability. * **Syphilis & Gonorrhea:** These are diagnosed via serology (VDRL/RPR), dark-field microscopy, or Gram stain/culture, rather than a logarithmic bacterial index. **High-Yield Clinical Pearls for NEET-PG:** * **Morphological Index (MI):** Measures the percentage of **solidly staining** (viable) bacilli. It is used to assess the immediate response to chemotherapy and early detection of drug resistance. * **BI vs. MI:** BI measures the *quantity* (load), while MI measures the *viability* (quality) of the bacteria. * **Standard Sites:** Smears are typically taken from 4-6 sites, including both earlobes and two active lesions. * **Ridley-Jopling Scale:** BI is highest in Lepromatous Leprosy (LL) and lowest/zero in Tuberculoid Leprosy (TT).
Explanation: **Explanation:** The classification of obesity is based on the **Body Mass Index (BMI)**, calculated as weight in kilograms divided by the square of height in meters ($kg/m^2$). According to the World Health Organization (WHO) and standard clinical guidelines, **Morbid Obesity (Class III Obesity)** is defined as a **BMI > 40 $kg/m^2$**. This stage represents a critical level of adiposity where the risk of life-threatening comorbidities (such as Type 2 Diabetes, Obstructive Sleep Apnea, and Cardiovascular Disease) increases exponentially. **Analysis of Options:** * **Option B (Correct):** BMI > 40 is the threshold for Morbid Obesity. It is also the criteria for considering bariatric surgery in patients without other comorbidities. * **Option A:** BMI > 30 is the general threshold for **Obesity (Class I)**. * **Option C:** BMI > 35 is classified as **Class II Obesity** (Severe Obesity). * **Option D:** BMI > 29 (specifically 25–29.9) is categorized as **Overweight**. **High-Yield Clinical Pearls for NEET-PG:** 1. **Asian-Indian Specific Criteria:** Due to a higher risk of metabolic syndrome at lower BMIs, the criteria for Indians are lower: * Overweight: 23–24.9 $kg/m^2$ * Obesity: $\ge$ 25 $kg/m^2$ 2. **Ponderal Index:** Unlike BMI, this uses the cube of height ($kg/m^3$) and is a more sensitive indicator for fetal growth. 3. **Waist-Hip Ratio:** A high-yield marker for "Central Obesity." Significant if **> 0.9 in men** or **> 0.85 in women**. 4. **Quetelet's Index:** Another name for the Body Mass Index.
Explanation: **Explanation:** In the context of Post-Exposure Prophylaxis (PEP) for Rabies, the schedule (0, 3, 7, 14, 28/30, and optional 90 days) refers to the timing of vaccine administration. **Day '0' represents the day the first dose of the vaccine is administered**, not the day of the bite itself. This is a critical distinction because patients may present to a clinic several days after the actual exposure. **Analysis of Options:** * **Day of first injection (Correct):** Medical protocols define Day 0 as the initiation of treatment. All subsequent doses (Day 3, 7, etc.) are calculated based on this first visit to ensure the correct immunological interval for antibody production. * **Day of dog bite:** While ideally the vaccine is started on the day of the bite, Day 0 specifically marks the start of the medical intervention. If a patient presents 3 days after a bite, that day becomes their "Day 0." * **Day of symptom onset:** Rabies is 100% fatal once clinical symptoms appear. Vaccination is a preventive measure; once symptoms start, the vaccine is no longer effective. * **Day of dog death:** The 10-day observation period of the animal is used to decide whether to *continue* or *stop* the vaccine series, but it does not define the start date of the schedule. **High-Yield Clinical Pearls for NEET-PG:** * **Essen Schedule:** The 5-dose Intramuscular (IM) regimen (0, 3, 7, 14, 28). The 90th-day dose is now considered optional/historical. * **Updated Thai Red Cross Schedule (IDRV):** The current WHO-recommended intradermal regimen is **2-2-2** (2 doses on days 0, 3, and 7). * **Site of Injection:** Deltoid muscle in adults; anterolateral thigh in children. **Never** in the gluteal region (reduced immunogenicity due to fat). * **Category III Bites:** Require both Rabies Vaccine and Rabies Immunoglobulin (RIG) on Day 0.
Explanation: **Explanation:** Non-Communicable Diseases (NCDs) are the leading cause of mortality globally and in India, accounting for approximately 74% of all deaths worldwide. Understanding the relative burden of these diseases is crucial for public health prioritization. **1. Why the Correct Answer is Right:** According to the World Health Organization (WHO), the hierarchy of NCD mortality is consistently led by **Cardiovascular Diseases (CVDs)**. The global and national distribution of NCD deaths follows this specific order: * **Cardiovascular Diseases:** ~17.9 million deaths/year (Leading cause). * **Cancers:** ~9.3 million deaths/year. * **Chronic Respiratory Diseases:** ~4.1 million deaths/year (e.g., COPD, Asthma). * **Diabetes:** ~2.0 million deaths/year. This sequence (**CVD > Cancer > Respiratory > Diabetes**) reflects the high prevalence of metabolic risk factors (hypertension, dyslipidemia) and lifestyle factors (tobacco, physical inactivity) that primarily drive cardiac mortality. **2. Why Other Options are Wrong:** * **Option A & B:** These incorrectly place Respiratory diseases or Cancers above CVDs. While respiratory diseases are high in India due to biomass fuel and pollution, they do not surpass CVDs or Cancers globally. * **Option D:** Diabetes, while a major morbidity factor and a "silent killer," has a lower direct mortality rate compared to the acute events associated with stroke, myocardial infarction, or advanced malignancy. **3. NEET-PG High-Yield Pearls:** * **The "Big Four":** These four diseases (CVD, Cancer, Respiratory, Diabetes) are the primary targets of the **National Programme for Prevention & Control of NCDs (NP-NCD)**. * **Global Target:** The WHO "25 by 25" goal aims for a 25% relative reduction in overall mortality from these four NCDs by 2025. * **Risk Factors:** Tobacco use is the common shared risk factor for all four major NCDs. * **India Context:** In India, CVDs also remain the #1 killer, but Chronic Respiratory Diseases (specifically COPD) have a disproportionately higher burden compared to global averages.
Explanation: The **WHO STEPwise approach to Surveillance (STEPS)** is a standardized method developed by the World Health Organization for collecting, analyzing, and disseminating data on **Non-Communicable Diseases (NCDs)** and their risk factors. ### Why Option B is Correct: The STEPS program is specifically designed to help countries monitor the growing burden of NCDs (like Diabetes, Hypertension, and CVDs) by tracking common risk factors. It uses a hierarchical 3-step framework: * **Step 1 (Socio-demographic & Behavioral):** Questionnaires regarding tobacco use, alcohol consumption, diet, and physical activity. * **Step 2 (Physical Measurements):** Objective data like Blood Pressure, Height, Weight (BMI), and Waist Circumference. * **Step 3 (Biochemical Measurements):** Laboratory tests for Blood Glucose and Cholesterol levels. ### Why Other Options are Incorrect: * **Option A (Communicable diseases):** These are monitored via the Integrated Disease Surveillance Programme (IDSP) or specific vertical programs (e.g., RNTCP for TB), focusing on incidence and transmission rather than lifestyle risk factors. * **Options C & D (Immunodeficient/Autoimmune):** These are specialized clinical conditions. While they are non-communicable, they are not the focus of the "STEPS" population-level surveillance, which targets lifestyle-related metabolic risks. ### High-Yield Facts for NEET-PG: * **Goal:** To provide "comparable data" across different countries to help formulate public health policies. * **Core vs. Expanded:** Each step has "Core" (minimum required) and "Expanded" (optional) modules. * **Global Burden:** NCDs are responsible for approximately 70% of all deaths globally; STEPS is the primary tool for the WHO Global Action Plan for the Prevention and Control of NCDs.
Explanation: ### Explanation **Correct Option: A (Age above 7 years)** In India, the **Literacy Rate** is defined as the percentage of the population aged **7 years and above** who can both read and write with understanding in any language. A person who can only read but cannot write is not considered literate. The age of 7 is chosen as the threshold because it is the age by which a child is expected to have developed basic cognitive and motor skills required for formal reading and writing. **Analysis of Incorrect Options:** * **B & C (Schooling up to 10th class/15 years):** Formal schooling is not a prerequisite for literacy. A person can be literate through non-formal education or self-learning without ever attending a school or completing a specific grade. * **D (Whole population):** Calculating literacy for the entire population (including infants and toddlers) would provide a skewed and inaccurate representation of a country's educational status, as children below age 5-6 are biologically not expected to be literate. **High-Yield NEET-PG Pearls:** * **Crude Literacy Rate:** Calculated using the *total population* as the denominator. * **Effective Literacy Rate (Standard):** Calculated using the population *aged 7+ years* as the denominator. This is the standard used in the Indian Census. * **Indicator of Development:** Literacy is a key component of the **Physical Quality of Life Index (PQLI)** and the **Human Development Index (HDI)**. * **Gender Gap:** The difference between male and female literacy rates is a sensitive indicator of social development and gender equity in a community.
Epidemiology of NCDs
Practice Questions
Cardiovascular Disease Prevention
Practice Questions
Diabetes Control Program
Practice Questions
Cancer Screening and Control
Practice Questions
Chronic Respiratory Diseases
Practice Questions
Mental Health Program
Practice Questions
Blindness Control Program
Practice Questions
Accident and Injury Prevention
Practice Questions
NCD Risk Factor Surveillance
Practice Questions
National Program for Prevention and Control of Cancer, Diabetes, CVD, and Stroke
Practice Questions
Oral Health Program
Practice Questions
Geriatric Health Issues
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free